|
|
|
|
Paradigm
Shift
Viral
Evolution
Intervention
Monitoring
Vaccine
Screening
Vaccine
Development
Expression
Profiling
Drug
Discovery
Custom
Therapies
Patents
|
|
|
Audio: Jan28 Apr21 Sep22
Commentary
Confirmed
B2H2H2H2H H5N1 Transmission in Pakistan
Recombinomics Commentary
16:02
October 4, 2008
With
respect to the chain of transmission, evidence gathered during the
investigation supports the theory of initial transmission from poultry
to humans followed by human-to-human transmission involving a third
generation.
Case 5 was a 33-year-old
brother of Case 1. He was asymptomatic but clinical specimens were
collected from him owing to the close and prolonged contact with his
ill brothers. Initial testing at the National Institute of Health
yielded positive results for H5 RT–PCR on a throat swab collected on 29
November. When serum specimens were tested by microneutralization
assay, a specimen collected on 8 December yielded an H5 antibody titre
of 1:320 and a positive western blot assay.
The above comments are from WHO’s Oct 3 Weekly epidemiological record
(WER), which includes a report entitled
“Human cases of avian influenza A(H5N1) in North-West Frontier
Province, Pakistan, October-November 2007”. As indicated in the
title, the report is coming out almost a full year since the start of
the outbreak, and as indicated in the quotes above, includes an
asymptomatic brother who was H5N1 confirmed by three different lab
tests. However, these results have not been released previously,
and the newly described case extends the transmission chain to
B2H2H2H2H, which is the longest recorded to date for H5N1.
Moreover, even though the case is acknowledged in this week's report,
the case has not been added to the WHO table of confirmed
H5N1 cases. These delays and omissions extend the long list
of deficiencies in the detection and reporting of this historic and
important H5N1 outbreak in Pakistan.
The report provides detail that was lacking for months after the
outbreak began, and clears up a subset of the long list of questions
raised by the outbreak. However, many important issues, including
the sequence of the H5N1 isolated from the first confirmed case, which
remains in WHO’s private password protected database, along with
hundreds if not thousands of H5N1 sequences from infected patients or
other hosts, remain unresolved.
As noted in the report, the transmission chain began when one of the
cullers was infected in October (B2H) and developed symptoms on October
29, 2007. He then infected one of his brothers (B2H2H) who
developed symptoms on November 12 and died a week later, but not before
the brother infected two more brothers (B2H2H2H) who developed symptoms
on November 21. One of these brothers died November 28 and one
infected a fifth brother (B2H2H2H2H) who was asymptomatic, but as noted
above, was H5N1 positive by three lab tests, including PCR on a nasal
swab collected November 29.
However, none of the above was made public until there were local media
reports, which were picked up by internet discussion groups in early
December, 2007. The story was subsequently picked up by wire
services followed by comments by agencies in Pakistan or WHO.
However, the initial stories were largely confusing, in part because of
the long delay between the start of the outbreak and the start of media
coverage. Consequently some stories noted that the outbreak began
in October, while others assumed the outbreak began in December, just
prior to the media stories.
In addition to
the brothers described above, other cullers and contacts were also said
to be H5N1 positive based on testing done in Pakistan. However,
by the time investigators from WHO regional centers in Egypt and
England arrived, the samples had largely degraded and initially the
only positive was a sample from the brother who died November 28.
A sample from the brother who died November 19 was not tested (although
at least one local media report indicated a sample had been collected),
and samples from the brothers who were hospitalized and recovered
tested negative. The time of the testing of the asymptomatic
remains unclear, because the WER indicates the sample collected
November 29 was PCR positive, yet this positive result was not
disclosed prior to this week.
However, in addition to the long delay in the acknowledgment of the
asymptomatic case and the failure to test the first fatal case, the two
cases who recovered were not reported confirmed until April,
when results from neutralizing antibody tests were reported. It
is unclear if these delays were linked to the establishment of a new
test using the H5N1 isolated from the second fatal case as a target,
because the sequence of this isolate has been withheld.
Therefore, it is unclear if there were significant differences in
sequence between the human isolate and other available targets.
However, since
the titer for the index case was 1:2560 and the recovered brother was
1:320, as was the asymptomatic brother, it seems likely that these high
titers would have been detected when the samples were collected in late
November or early December. Thus, the reasons for the four month
delay in reporting the confirmation of the two recovered brothers or
the 10 month delay in reporting the asymptomatic case remains unclear,
as is the reason for the failure to add the asymptomatic case to the
list of H5N1 confirmed cases, since the brother was H5N1 positive in
three lab tests (PCR, neutralizing antibody, and Western blot).
The reporting delays associated with the longest human to human H5N1
transmission recorded to date has been followed by questionable reports
by other countries. The H5N1 in Pakistan was followed by massive
outbreaks in India (West Bengal) and adjacent Bangladesh.
Bangladesh has acknowledged one human case, which was also reported
months after the fact. The location of the reported case in the slums
of Dhaka strongly suggests that the number of human cases in
Bangladesh and India was markedly higher than one. India has yet to
report any human cases, although the bird flu symptoms in villagers
were wildly reported, as was the similarity in sequence between the
H5N1 in India and Bangladesh, although neither country has released
sequences from these outbreaks (and Bangladesh has not released
sequences from any H5N1 outbreak).
Similarly, H5N1 clusters in Indonesia have been denied.
Fatally infected index cases from clusters that involve H5N1 confirmed
cases have been said to have died from respiratory
disease, typhus,
and dengue
fever, which has raised serious credibility issues with regard to
reporting from Indonesia, and WHO was stopped reporting confirmed H5N1
cases in Indonesia in a timely manner. Instead of the mandated
IHR reporting time of 24-48 hours, WHO has been reporting H5N1 cases
weeks or months after lab confirmation, setting the precedent for more
reporting violations, including South Korea who refused
to acknowledge a soldier/culler who was H5
PCR positive earlier this year.
In addition to the delays or lack of reports on H5N1 cases and
clusters, WHO regional centers continue to hoard H5N1 sequences in the
WHO private database. NAMRU-3 became a WHO regional center last
year and has not released any human H5N1 sequences since, even though
cases were confirmed at the end of 2007 and beginning of 2008.
Sequences from West Bengal have been sequestered at Genbank for several
months (see list here),
and over 170 HA H5N1 sequences from Turkey have also been sequestered
at Genbank for several months (see list here
here
here
here
here).
These reporting failures coupled with the hoarding of H5N1 sequence
data by WHO and regional centers continue to be cause for concern and
continue to be hazardous to the world’s health.
Media Links
Recombinomics Presentations
Recombinomics
Publications
Recombinomics
Paper
at Nature Precedings
|